Houston / Wakayama / Lima / Tokyo / Pittsburgh / Kanagawa / Chemotherapy / /
Company
Giralt SA / Checkpoint / Amgen / Internal Medicine / Genentech / EMD Serono Inc. / Pagliaro LC / Afanasyev BV / Acholonu SA / Issued Technology Licenses Sysmex Corporation / Pharmacia / Immunex / Faculty Associates / Kyowa Hakko Kirin Co. Ltd. / M. D. Anderson Associates / Anderson Cancer Center Breast Cancer Translational Research Laboratory / AstraZeneca / /
Continent
North America / /
Country
Japan / Australia / United States / /
Currency
USD / pence / /
Event
FDA Phase / /
Facility
Granting Education Wakayama Medical College / University of Texas Health Science Center / A CITIZENSHIP HOME ADDRESS OFFICE ADDRESS The University of Texas MD Anderson Cancer Center / Naval Hospital / Mitotic Checkpoint / University of Texas / Anderson Cancer Center / The University of Texas MD Anderson Cancer Center RESEARCH Grants / University of Texas MD Anderson Cancer Center / University of Pittsburgh / The University of Texas MD Anderson Cancer Center / Pittsburgh Medical Center / Montefiore University Hospital / Medicine The University of Texas Graduate School / Technology Licenses Patents University of Texas System / St. Luke International Hospital / United States Naval Hospital / / /
IndustryTerm
cancer therapies / therapy for high-risk primary breast cancer / therapy for ERK Pathway in Breast Cancer / therapy for idiopathic hypereosinophilic syndrome / cancer care / therapy of leukemia / Cancer Treat / treatment of acute myeloid leukemia / Bone imaging / treatment of idiopathic hypereosinophilic syndrome / Treatment of Metatastic Breast Cancer / /
MedicalCondition
ovarian cancer / hormone-dependent metastatic breast cancer / enteritis / JE / multiple myeloma / primary breast cancer / inflammatory breast carcinoma / independent prostrate cancer / long-term disease / Weber RS. Primary malignant teratoma / Breast Cancer / Advanced Solid Tumor / high-risk primary breast cancer / Metatastic Breast Cancer / Leukemia / Tumor / advanced Hodgkin's disease / Cancer / Bone Only Metastases / Whimbey E. Cytomegalovirus pneumonia / high-risk myelodysplastic syndrome / Hodgkin's lymphoma / Ancient Retrovirus During Breast Cancer / ovarian cancer SKOV3.ip1 / idiopathic hypereosinophilic syndrome / breast and ovarian cancer / therapy-related myelodysplastic syndrome/acute leukemia / acute myeloid leukemia / Whimbey E. Respiratory syncytial virus infections / DF / myelodysplastic syndromes / metastasis / graft-versus-host disease / advanced ovarian cancer / metastatic solid tumors / solid tumors / metastatic breast cancer undergoing high-dose chemotherapy / metastatic breast cancer / advanced myelodysplastic syndrome / high-risk malignant lymphoma / Idiopathic pneumonia syndrome / triple-negative breast cancer / breast and kidney cancer / human breast cancer / non-Hodgkin's lymphoma / disease / human xenograft tumor / Inflammatory Breast Cancer / high-risk breast cancer / metastatic renal cell carcinoma / hematologic malignancies / breast cancer refractory / acute myelogenous leukemia / /
PI / Academy of Cancer Expert / Program Advisory Committee / Houston Endowment / Division of Cancer Medicine / Cancer Center / St. Luke International Hospital / Tokyo Hospital Pharmacists Association / Canadian Grant Agency / American Board of Internal Medicine / University of Texas Health Science Center at Houston / Degree-Granting Education Wakayama Medical College / Inflammatory Breast Cancer Foundation / Technology Licenses Patents University of Texas System / United States Naval Hospital / Asia Task Force / Montefiore University Hospital / Lance Armstrong Foundation / Project Member / Education and Research Center for Stem Cell Medicine / AstraZeneca Medical Education Grants Office / AACR Clinical and Translational Cancer Research Fellowships Scientific Review Committee / Breast Medical Oncology Department Concepts & Protocols Review Committee / St. Luke Life Science Institute / Japanese International Advisory Committee / Department of Medicine / Milford / African Union / Susan G. Komen Breast Cancer Foundation / Service on Study Sections Page / Board of Regents / Pittsburgh Medical Center / Health Sciences Centre Foundation / Reviewer / University of Texas / National Institute of Health / Targeted Therapy Review Committee / Department of Breast Medical Oncology / Grant Review Committee / Department of Molecular and Cellular Oncology / CancerCare Manitoba Foundation / Keio University Sister Institution Committee / Tokyo Japan / University of Texas Graduate School / University of Pittsburgh / Pittsburgh / Global Academic Programs Steering Committee / Educational Role Recognition Committee / Intravenous administration / St. Luke Life Science Foundation / Division of Medicine / Department of Defense / Governmental Service U.S. Naval Hospital / Institutional Committee Activities Fellows Education Committee / Department of Hematology / /
Person
Grant Reviewer / Inflammatory Breast / Identification / Nonmyeloablative Allogeneic Hematopoietic / Valero V / Nonmyeloablative Allogeneic / Ann Oncol / Morgan Welch Inflammatory / Jesse H. Jones / Saya H. Functional / Naoto Tada Ueno / Grant Review / Hung M. Growth / Stem Cell / Transplantation / Robert M. Chamberlain Distinguished Mentor / Associazione Italiana / Educational Role / / /
Position
Funded Principal Investigator / Appointments/Responsibilities Leader / Executive Director / Principal Investigator / My Oncology Dream Award / Professor / with Tenure / Vice Chair / Cytogen Principal Investigator / Co-Investigator / Development / Professor / Principal Investigator / Japan TeamOncology Program / Berlex Principal Investigator / Associate Professor / Investigator / Board Member / Principal Investigator / Abraxis Bio Principal Investigator / TX Executive Director / The / Co-Investigator / Escalon MP / Consultant / Program Leader / Medical Advisor / Principal Investigator / Development / Chairman / Director / TAP Pharmaceutical Principal Investigator / Cellerant Therapeutics Principal Investigator / Assistant Professor / Chair / Section Chief / TITLE AND AFFILIATION Primary Appointment Section Chief / /
CURRICULUM VITAE Naoto Tada Ueno, M.D., Ph.D., F.A.C.P. PRESENT TITLE AND AFFILIATION Primary Appointment Section Chief, Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, Division of